GM-CSF (sargramostim)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GM-CSF (sargramostim), covering 2009-09-09 to 2012-11-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant With Ovarian, Tubal or Peritoneal Cancer [Phase 1]